Health
Rutgers leading a clinical trial assessing combination treatment for coronavirus – News-Medical.Net
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with…
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted with Synavir Corporation, a global health company that works with academia, industry and government to develop combination treatments for new viral infections.
The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine…
-
Noosa News18 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General17 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General20 hours agoMan dies at shopping centre car park at Charlestown following reports of assault
-
Noosa News16 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace